Skip to Main Content

Author Details

Daniel W Chan
Division of Clinical Chemistry, Johns Hopkins University
1979
300
80
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36097168Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.Prostate Cancer Prostatic Dis2024
36097168Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.Prostate Cancer Prostatic Dis2024
38029961Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum.Mol Cell Proteomics2024
38029961Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum.Mol Cell Proteomics2024
37357306VCAM-1 complements CA-125 in detecting recurrent ovarian cancer.Clin Proteomics2023
36973268Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Nat Commun2023
37198186Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Nat Commun2023
37357306VCAM-1 complements CA-125 in detecting recurrent ovarian cancer.Clin Proteomics2023
36973268Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Nat Commun2023
37198186Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Nat Commun2023
36393853Strategies for developing long-lasting therapeutic nucleic acid aptamer targeting circulating protein: The present and the future.Front Cell Dev Biol2022
35830553Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.J Urol2022
36266629Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma.Clin Proteomics2022
35411226Improving the detection of aggressive prostate cancer using immunohistochemical staining of protein marker panels.Am J Cancer Res2022
36393853Strategies for developing long-lasting therapeutic nucleic acid aptamer targeting circulating protein: The present and the future.Front Cell Dev Biol2022
35411226Improving the detection of aggressive prostate cancer using immunohistochemical staining of protein marker panels.Am J Cancer Res2022
35830553Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.J Urol2022
36266629Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma.Clin Proteomics2022
33417831Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.Cancer Cell2021
33704733Detection of Uveal Melanoma by Multiplex Immunoassays of Serum Biomarkers.Methods Mol Biol2021
33472913Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).Clin Cancer Res2021
33995654A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer.Theranostics2021
33417831Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.Cancer Cell2021
34944713Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays.Biomedicines2021
33704733Detection of Uveal Melanoma by Multiplex Immunoassays of Serum Biomarkers.Methods Mol Biol2021
34944713Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays.Biomedicines2021
33995654A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer.Theranostics2021
33472913Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).Clin Cancer Res2021
32534439Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes.iScience2020
32305266Development and evaluation of the MiCheck test for aggressive prostate cancer.Urol Oncol2020
32110166Correction to: Proteomic analysis of degradation ubiquitin signaling by ubiquitin occupancy changes responding to 26S proteasome inhibition.Clin Proteomics2020
31997977Proteomic analysis of degradation ubiquitin signaling by ubiquitin occupancy changes responding to 26S proteasome inhibition.Clin Proteomics2020
31923397Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.Cell2020
31859488An Integrated Workflow for Global, Glyco-, and Phospho-proteomic Analysis of Tumor Tissues.Anal Chem2020
33262351Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.Nat Commun2020
33204318Urinary glycoproteins associated with aggressive prostate cancer.Theranostics2020
32534439Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes.iScience2020
32529193Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.Cell Rep Med2020
33287876Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets.J Hematol Oncol2020
33067450A high-stringency blueprint of the human proteome.Nat Commun2020
32954372Correction: Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.Cell Rep Med2020
32719746Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL).Front Oncol2020
31997977Proteomic analysis of degradation ubiquitin signaling by ubiquitin occupancy changes responding to 26S proteasome inhibition.Clin Proteomics2020
31923397Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.Cell2020
31859488An Integrated Workflow for Global, Glyco-, and Phospho-proteomic Analysis of Tumor Tissues.Anal Chem2020
33287876Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets.J Hematol Oncol2020
33262351Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.Nat Commun2020
33067450A high-stringency blueprint of the human proteome.Nat Commun2020
33204318Urinary glycoproteins associated with aggressive prostate cancer.Theranostics2020
32719746Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL).Front Oncol2020
  • 1 - 50 of 600

Recommended Authors

Christopher Louden
University of Texas Health Science Center at San Antonio
Career Start Year 2011
Number of shared co-authors 1
Joely A Straseski
University of Utah Health Sciences Center
Career Start Year 2009
Number of shared co-authors 5
Ioannis Prassas
Mount Sinai Hospital
Career Start Year 2007
Number of shared co-authors 4
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 2
Elisa Pin
KTH Royal Institute of Technology
Career Start Year 2007
Number of shared co-authors 5
Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Career Start Year 2006
Number of shared co-authors 7
Brian L Hood
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Career Start Year 2004
Number of shared co-authors 5
Sharon J Pitteri
Stanford University
Career Start Year 2003
Number of shared co-authors 22
Melinda Rezeli
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 2002
Number of shared co-authors 19
Stella Somiari
Windber Research Institute
Career Start Year 2000
Number of shared co-authors 3
Antoninus Soosaipillai
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 2000
Number of shared co-authors 2
??kos V??gv??ri
Karolinska Institutet
Career Start Year 1998
Number of shared co-authors 20
Thomas P Conrads
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1998
Number of shared co-authors 21
Julius O Nyalwidhe
Eastern Virginia Medical School
Career Start Year 1997
Number of shared co-authors 7
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 13
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 10
Mu Wang
Academy of Pharmacy, Xi'an Jiaotong-Liverpool University
Career Start Year 1996
Number of shared co-authors 9
Robert Kim
University of California
Career Start Year 1996
Number of shared co-authors 5
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 5
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 7
Richard R Drake
Medical University of South Carolina
Career Start Year 1989
Number of shared co-authors 11
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 10
Johan Lindberg
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 7
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 14
Fred C G J Sweep
Radboud University Medical Centre
Career Start Year 1987
Number of shared co-authors 4
Michael J Becich
University of Pittsburgh School of Medicine
Career Start Year 1982
Number of shared co-authors 5
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 7
Eric J Bergstralh
Mayo Clinic
Career Start Year 1980
Number of shared co-authors 7
Leslie M Shaw
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1968
Number of shared co-authors 0

Collaborators

Lori J Sokoll
Division of Clinical Chemistry, Johns Hopkins University
Co-authored papers 95
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 63
Zhen Zhang
Co-authored papers 62
Hui Zhang
Co-authored papers 50
Henry Rodriguez
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 21
Christopher R Kinsinger
Co-authored papers 19
Richard D Smith
Pacific Northwest National Laboratory
Co-authored papers 17
Qing Kay Li
Co-authored papers 14
Lijun Chen
Co-authored papers 13
Tao Liu
Pacific Northwest National Laboratory
Co-authored papers 13
Karin D Rodland
Oregon Health and Science University
Co-authored papers 12
Gilbert S Omenn
and School of Public Health, University of Michigan ann arbor
Co-authored papers 12
Emily S Boja
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 12
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 11
Sudhir Srivastava
National Cancer Institute
Co-authored papers 10
Mehdi Mesri
Co-authored papers 10
Michael Schnaubelt
Co-authored papers 10
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers 10
Robert L Moritz
Institute for Systems Biology
Co-authored papers 9
Reid Townsend
Co-authored papers 9
Bing Zhang
Baylor College of Medicine
Co-authored papers 9
Yingwei Hu
Co-authored papers 9
George G Klee
Mayo Clinic
Co-authored papers 9
Stefani N Thomas
Co-authored papers 9
Matthew J Ellis
Co-authored papers 8
Bai Zhang
Co-authored papers 8
Shisheng Sun
Co-authored papers 8
David L Tabb
Co-authored papers 8
Yuan Tian
Co-authored papers 8
Ruedi Aebersold
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 7
Release 1.2